SHE: 000989

Company Drug

Jiuzhitang’s Stem Cell Therapy for Autism Receives NMPA Clinical Trial Approval

Fineline Cube Mar 13, 2025

China-based Jiuzhitang Co. Ltd (SHE: 000989) announced receiving clinical trial approval from the National Medical...

Company Drug

Jiuzhitang Co., Ltd Announces Clinical Clearance for Volagidemab in Type 1 Diabetes

Fineline Cube Nov 4, 2024

China-based traditional Chinese medicine (TCM) giant Jiuzhitang Co., Ltd (SHE: 000989) has announced that volagidemab...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod